Clinical Trial Update: CXCR4 Antagonism for Cell Mobilisation and Healing in Acute Myocardial Infarction (CATCH-AMI) [Phase 2]

View source ↗

Summary

A Phase 2 study investigating a CXCR4 antagonist for cell mobilization and healing in patients with large reperfused ST-elevation myocardial infarction has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• St-elevation Myocardial Infarction

Drugs mentioned

• CXCR4 antagonist (Polyphor investigational) (CXCR4 antagonist)

Snippet

Sponsor: Polyphor Ltd. | Conditions: Large Reperfused ST-Elevation Myocardial Infarction | Phase 2 | Status: COMPLETED